On ECHEMI
Home > Drugs > Acquired abnormalities of coagulation factors due to severe liver disease
Acquired abnormalities of coagulation factors due to severe liver disease
Severe liver disease causes acquired abnormalities in coagulation factors, mainly due to liver disease. Because most coagulation factors are synthesized in the liver, when the liver is diseased, coagulation disorders are often associated.
  • Site of disease:

    Whole body liver
  • Infectious :

    Not contagious
  • Frequent population:

    More common in people with liver disease
  • Related symptoms:

    Bleeding gums Heavy menstruation Thrombocytopenia Skin and mucous membrane bleeding Liver disease face
  • Concurrent disease:

Related Drugs
Human fibrinogen
Indication: 1. Congenital hypofibrinogenemia or deficiency. 2. Acquired hypofibrinogenemia: severe liver damage; liver cirrhosis; disseminated intravascular coagulation; postpartum hemorrhage and coagulation disorders caused by fibrinogen deficiency due to major surgery, trauma or internal bleeding.
Manufacturer:

Nuoyi Biopharmaceutical Co., Ltd.

Human fibrinogen
Indication: 1. Congenital hypofibrinogenemia or deficiency. 2. Acquired hypofibrinogenemia: severe liver damage; liver cirrhosis; disseminated intravascular coagulation; postpartum hemorrhage and coagulation disorders caused by fibrinogen deficiency due to major surgery, trauma or internal bleeding.
Manufacturer:

Harbin Pesfico Biopharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.